From the Departments of Radiology (C.E., P.M., F.F., J.K.D.), Medical Imaging and Radiation Sciences (M.E.M.), and Medicine (M.P.S., D.F., P.M., I.S.C., N.R., P.W., A.V., M.D.), Thomas Jefferson University, Philadelphia, Pa; Clarius Mobile Health, Vancouver, Canada (K.D.); and Department of Radiology, Mayo Clinic, Rochester, Minn (J.K.D).
Radiol Cardiothorac Imaging. 2024 Feb;6(1):e230153. doi: 10.1148/ryct.230153.
Purpose To investigate if the right ventricular (RV) systolic and left ventricular (LV) diastolic pressures can be obtained noninvasively using the subharmonic-aided pressure estimation (SHAPE) technique with Sonazoid microbubbles. Materials and Methods Individuals scheduled for a left and/or right heart catheterization were prospectively enrolled in this institutional review board-approved clinical trial from 2017 to 2020. A standard-of-care catheterization procedure was performed by advancing fluid-filled pressure catheters into the LV and aorta ( = 25) or RV ( = 22), and solid-state high-fidelity pressure catheters into the LV and aorta in a subset of participants ( = 18). Study participants received an infusion of Sonazoid microbubbles (GE HealthCare), and SHAPE data were acquired using a validated interface developed on a SonixTablet (BK Medical) US scanner, synchronously with the pressure catheter data. A conversion factor, derived using cuff-based pressure measurements with a SphygmoCor XCEL PWA (ATCOR) and subharmonic signal from the aorta, was used to convert the subharmonic signal into pressure values. Errors between the pressure measurements obtained using the SHAPE technique and pressure catheter were compared. Results The mean errors in pressure measurements obtained with the SHAPE technique relative to those of the fluid-filled pressure catheter were 1.6 mm Hg ± 1.5 [SD] ( = .85), 8.4 mm Hg ± 6.2 ( = .04), and 7.4 mm Hg ± 5.7 ( = .09) for RV systolic, LV minimum diastolic, and LV end-diastolic pressures, respectively. Relative to the measurements with the solid-state high-fidelity pressure catheter, the mean errors in LV minimum diastolic and LV end-diastolic pressures were 7.2 mm Hg ± 4.5 and 6.8 mm Hg ± 3.3 ( ≥ .44), respectively. Conclusion These results indicate that SHAPE with Sonazoid may have the potential to provide clinically relevant RV systolic and LV diastolic pressures. Ultrasound-Contrast, Cardiac, Aorta, Left Ventricle, Right Ventricle ClinicalTrials.gov registration no.: NCT03245255 © RSNA, 2024.
目的 探讨使用 SonoVue 微泡的次谐波辅助压力估计 (SHAPE) 技术是否可以无创获得右心室 (RV) 收缩压和左心室 (LV) 舒张压。
材料与方法 本研究为前瞻性临床试验,纳入 2017 年至 2020 年期间拟行左心和/或右心导管检查的患者。通过向 LV 和主动脉(n = 25)或 RV(n = 22)中推进充满液体的压力导管,以及向部分参与者的 LV 和主动脉中推进固态高保真压力导管(n = 18)进行标准的导管检查程序。研究参与者接受 SonoVue 微泡(GE HealthCare)输注,并使用在 SonixTablet(BK Medical)US 扫描仪上开发的经过验证的接口获取 SHAPE 数据,与压力导管数据同步采集。使用基于袖带的 SphygmoCor XCEL PWA(ATCOR)与主动脉次谐波信号的压力测量转换系数,将次谐波信号转换为压力值。比较使用 SHAPE 技术获得的压力测量值与压力导管测量值之间的误差。
结果 与充满液体的压力导管相比,SHAPE 技术获得的压力测量值的平均误差分别为 RV 收缩压 1.6 ± 1.5 mm Hg(n =.85)、LV 最小舒张末期压 8.4 ± 6.2 mm Hg(n =.04)和 LV 舒张末期压 7.4 ± 5.7 mm Hg(n =.09)。与固态高保真压力导管相比,LV 最小舒张末期压和 LV 舒张末期压的平均误差分别为 7.2 ± 4.5 mm Hg 和 6.8 ± 3.3 mm Hg(≥.44)。
结论 这些结果表明,SonoVue 联合 SHAPE 技术可能有潜力提供有临床意义的 RV 收缩压和 LV 舒张压。
超声造影剂,心脏,主动脉,左心室,右心室
NCT03245255
版权所有 2024 年,RSNA